RET gene rearrangements (RET/PTCs) represent together with BRAF point mutations the two major groups of mutations involved in papillary thyroid carcinoma initiation and progression. In this review, we will examine the mechanisms involved in RET/PTC-induced thyroid cell transformation. In detail, we will summarize the data on the molecular mechanisms involved in RET/PTC formation and in its function as a dominant oncogene, on the activated signal transduction pathways and on the induced gene expression modifications. Moreover, we will report on the effects of RET/PTCs on the tumor microenvironment including our recent findings on its actions on the immune cell component infiltrating the tumor and the peritumoral tissue. Finally, a short revi...
Rearrangements of the RET receptor tyrosine kinase gene generating RET/PTC oncogenes are specific to...
The tall-cell variant (TCV) of papillary thyroid carcinoma (PTC), characterized by tall cells bearin...
The activation of the RET proto-oncogene contributes to the development of human cancers in two dier...
Papillary thyroid carcinoma (PTC) is frequently associated with RET gene rearrangements that generat...
RET/PTC oncogenes are highly prevalent in papillary thyroid carcinoma, an indolent and well-differen...
Thyroid carcinoma is the most frequent endocrine cancer accounting for 5-10% of thyroid nodules. Pap...
The rearranged during transfection (RET) proto-oncogene was identified in 1985 and, very soon therea...
doi: 10.3389/fendo.2012.00067 Intracellular signal transduction and modification of the tumor microe...
Thyroid papillary carcinoma is the most common type of endocrine cancer. It is frequently associated...
OBJECTIVE: RET proto-oncogene rearrangements (ret/PTCs) represent the most common genetic alteration...
Papillary thyroid carcinomas (PTCs) are the most frequent type of malignant thyroid tumors. Somatic ...
Malignant tumors of the thyroid gland vary considerably in aggressiveness, ranging from a well-diffe...
We recently detected a novel activated oncogene by transfection analysis on NIH 3T3 cells in five ou...
We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. Th...
In papillary thyroid carcinomas (PTCs), rearrangements of the PET receptor (RET/PTC) and activating ...
Rearrangements of the RET receptor tyrosine kinase gene generating RET/PTC oncogenes are specific to...
The tall-cell variant (TCV) of papillary thyroid carcinoma (PTC), characterized by tall cells bearin...
The activation of the RET proto-oncogene contributes to the development of human cancers in two dier...
Papillary thyroid carcinoma (PTC) is frequently associated with RET gene rearrangements that generat...
RET/PTC oncogenes are highly prevalent in papillary thyroid carcinoma, an indolent and well-differen...
Thyroid carcinoma is the most frequent endocrine cancer accounting for 5-10% of thyroid nodules. Pap...
The rearranged during transfection (RET) proto-oncogene was identified in 1985 and, very soon therea...
doi: 10.3389/fendo.2012.00067 Intracellular signal transduction and modification of the tumor microe...
Thyroid papillary carcinoma is the most common type of endocrine cancer. It is frequently associated...
OBJECTIVE: RET proto-oncogene rearrangements (ret/PTCs) represent the most common genetic alteration...
Papillary thyroid carcinomas (PTCs) are the most frequent type of malignant thyroid tumors. Somatic ...
Malignant tumors of the thyroid gland vary considerably in aggressiveness, ranging from a well-diffe...
We recently detected a novel activated oncogene by transfection analysis on NIH 3T3 cells in five ou...
We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. Th...
In papillary thyroid carcinomas (PTCs), rearrangements of the PET receptor (RET/PTC) and activating ...
Rearrangements of the RET receptor tyrosine kinase gene generating RET/PTC oncogenes are specific to...
The tall-cell variant (TCV) of papillary thyroid carcinoma (PTC), characterized by tall cells bearin...
The activation of the RET proto-oncogene contributes to the development of human cancers in two dier...